Trials / Completed
CompletedNCT01930032
Pathogenic Mechanisms in C Diff Infection and Colitis
Pathogenic Mechanisms in Clostridium Difficile Infection and Colitis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 24 (actual)
- Sponsor
- Beth Israel Deaconess Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to learn more about infection by Clostridium difficile (also known as C. difficile). C. difficile is a common bacterium (a germ that may cause disease) that can live in the human gut. Some people have it without having any symptoms. In other people it can cause illness ranging from mild diarrhea to severe colitis (infection of the colon). C. difficile makes toxins that damage the cells that line the colon. The study doctors want to find out how these toxins cause damage to the cells in the colon.
Detailed description
The purpose of this study is to examine pathogenic mechanisms of Clostridium difficile toxin-mediated intestinal injury and inflammation. Two primary mechanisms will be examined. * To examine the hypothesis is that microRNA expression profiles are dysregulated by Clostridium difficile toxin exposure and that dysregulation of miRNA expression plays a role in the pathogenesis of C. difficile associated diseases. * To examine the hypothesis is that the TLR9 receptor mediates key inflammatory events in response to Clostridium difficile toxin exposure.
Conditions
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2014-01-01
- Completion
- 2014-01-01
- First posted
- 2013-08-28
- Last updated
- 2017-03-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01930032. Inclusion in this directory is not an endorsement.